Thymidine analogues suppress autophagy and adipogenesis in cultured adipocytes

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 1, 2013, Pages 543-551

  Stankov, Metodi V ^a   Panayotova Dimitrova, Diana ^b   Leverkus, Martin ^b   Schmidt, Reinhold E ^a   Behrens, Georg M N ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; NOCODAZOLE; RAPAMYCIN; REACTIVE OXYGEN METABOLITE; STAVUDINE; VINBLASTINE; ZIDOVUDINE;

ADIPOCYTE; ADIPOGENESIS; ARTICLE; AUTOPHAGY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADIPOCYTES; ADIPOGENESIS; ANDROSTADIENES; ANIMALS; AUTOPHAGY; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CHROMONES; FLOW CYTOMETRY; HUMANS; LAMIVUDINE; MICE; MICROSCOPY, FLUORESCENCE; MICROTUBULE-ASSOCIATED PROTEINS; MITOCHONDRIA; MORPHOLINES; NOCODAZOLE; PHAGOSOMES; REVERSE TRANSCRIPTASE INHIBITORS; RNA, SMALL INTERFERING; STAVUDINE; ZIDOVUDINE;

EID: 84872025463     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01560-12     Document Type: Article

References (42)

1. Carr A, Cooper DA. 2000. Adverse effects of antiretroviral therapy. Lancet 356:1423-1430.
2. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, Cooper DA. 1998. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12:F51-F58.
3. Stankov MV, Behrens GM. 2007. HIV-therapy associated lipodystrophy: experimental and clinical evidence for the pathogenesis and treatment. Endocr. Metab. Immune Disord. Drug Targets 7:237-249.
4. Nguyen A, Calmy A, Schiffer V, Bernasconi E, Battegay M, Opravil M, Evison JM, Tarr PE, Schmid P, Perneger T, Hirschel B. 2008. Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006. HIV Med. 9:142-150.
5. Nolan D, Hammond E, James I, McKinnon E, Mallal S. 2003. Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level. Antivir. Ther. 8:617-626.
6. Nolan D, Hammond E, Martin A, Taylor L, Herrmann S, McKinnon E, Metcalf C, Latham B, Mallal S. 2003. Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy. AIDS 17:1329-1338.
7. Domingo P, Matias-Guiu X, Pujol RM, Domingo JC, Arroyo JA, Sambeat MA, Vazquez G. 2001. Switching to nevirapine decreases insulin levels but does not improve subcutaneous adipocyte apoptosis in patients with highly active antiretroviral therapy-associated lipodystrophy. J. Infect. Dis. 184:1197-1201.
8. Domingo P, Matias-Guiu X, Pujol RM, Francia E, Lagarda E, Sambeat MA, Vázquez G. 1999. Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy. AIDS 13:2261-2267.
9. Bastard JP, Caron M, Vidal H, Jan V, Auclair M, Vigouroux C, Luboinski J, Laville M, Maachi M, Girard PM, Rozenbaum W, Levan P, Capeau J. 2002. Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance. Lancet 359:1026-1031.
10. Caron M, Auclair M, Lagathu C, Lombes A, Walker UA, Kornprobst M, Capeau J. 2004. The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro. AIDS 18:2127-2136.
11. Caron M, Auclairt M, Vissian A, Vigouroux C, Capeau J. 2008. Contribution of mitochondrial dysfunction and oxidative stress to cellular premature senescence induced by antiretroviral thymidine analogues. Antivir. Ther. 13:27-38.
12. Stankov MV, Lucke T, Das AM, Schmidt RE, Behrens GM. 2007. Relationship of mitochondrial DNA depletion and respiratory chain activity in preadipocytes treated with nucleoside reverse transcriptase inhibitors. Antivir. Ther. 12:205-216.
13. Stankov MV, Lucke T, Das AM, Schmidt RE, Behrens GM. 2010. Mitochondrial DNA depletion and respiratory chain activity in primary human subcutaneous adipocytes treated with nucleoside analogue reverse transcriptase inhibitors. Antimicrob. Agents Chemother. 54:280-287.
14. Stankov MV, Schmidt RE, Behrens GM. 2008. Zidovudine impairs adipogenic differentiation through inhibition of clonal expansion. Antimicrob. Agents Chemother. 52:2882-2889.
15. Stankov MV, Schmidt RE, Behrens GM. 2009. Combined effect of C-reactive protein and stavudine on adipogenesis. Antivir. Ther. 14:819-829.
16. Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O, Blomqvist L, Hoffstedt J, Naslund E, Britton T, Concha H, Hassan M, Ryden M, Frisen J, Arner P. 2008. Dynamics of fat cell turnover in humans. Nature 453:783-787.
17. Levine B, Kroemer G. 2008. Autophagy in the pathogenesis of disease. Cell 132:27-42.
18. Mizushima N, Yoshimori T, Levine B. 2010. Methods in mammalian autophagy research. Cell 140:313-326.
19. Baerga R, Zhang Y, Chen PH, Goldman S, Jin S. 2009. Targeted deletion of autophagy-related 5 (atg5) impairs adipogenesis in a cellular model and in mice. Autophagy 5:1118-1130.
20. Singh R, Xiang Y, Wang Y, Baikati K, Cuervo AM, Luu YK, Tang Y, Pessin JE, Schwartz GJ, Czaja MJ. 2009. Autophagy regulates adipose mass and differentiation in mice. J. Clin. Invest. 119:3329-3339.
21. Zhang Y, Goldman S, Baerga R, Zhao Y, Komatsu M, Jin S. 2009. Adipose-specific deletion of autophagy-related gene 7 (atg7) in mice reveals a role in adipogenesis. Proc. Natl. Acad. Sci. U. S. A. 106:19860-19865.
22. Walker UA, Setzer B, Venhoff N. 2002. Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors. AIDS 16:2165-2173.
23. Williams O. 2004. Flow cytometry-based methods for apoptosis detection in lymphoid cells. Methods Mol. Biol. 282:31-42.
24. Fung C, Lock R, Gao S, Salas E, Debnath J. 2008. Induction of autophagy during extracellular matrix detachment promotes cell survival. Mol. Biol. Cell 19:797-806.
25. Diessenbacher P, Hupe M, Sprick MR, Kerstan A, Geserick P, Haas TL, Wachter T, Neumann M, Walczak H, Silke J, Leverkus M. 2008. NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2. J. Invest. Dermatol. 128:1134-1147.
26. Kanki T, Klionsky DJ. 2010. The molecular mechanism of mitochondria autophagy in yeast. Mol. Microbiol. 75:795-800.
27. Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, Lam HC, Englert JA, Rabinovitch M, Cernadas M, Kim HP, Fitzgerald KA, Ryter SW, Choi AM. 2011. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12:222-230.
28. Wallace DC. 2005. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39:359-407.
29. Zhang Y, Qi H, Taylor R, Xu W, Liu LF, Jin S. 2007. The role of autophagy in mitochondria maintenance: characterization of mitochondrial functions in autophagy-deficient S. cerevisiae strains. Autophagy 3:337-346.
30. Gottlieb RA, Carreira RS. 2010. Autophagy in health and disease. 5. Mitophagy as a way of life. Am. J. Physiol. Cell Physiol. 299:C203-C210.
31. Gougeon ML, Penicaud L, Fromenty B, Leclercq P, Viard JP, Capeau J. 2004. Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations. Antivir. Ther. 9:161-177.
32. Lloreta J, Domingo P, Pujol RM, Arroyo JA, Baixeras N, Matias-Guiu X, Gilaberte M, Sambeat MA, Serrano S. 2002. Ultrastructural features of highly active antiretroviral therapy-associated partial lipodystrophy. Virchows Arch. 441:599-604.
33. Mallal SA, John M, Moore CB, James IR, McKinnon EJ. 2000. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS 14:1309-1316.
34. Kakuda TN. 2000. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin. Ther. 22:685-708.
35. Lagathu C, Bastard JP, Auclair M, Maachi M, Kornprobst M, Capeau J, Caron M. 2004. Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro. Antivir. Ther. 9:911-920.
36. Walker UA, Auclair M, Lebrecht D, Kornprobst M, Capeau J, Caron M. 2006. Uridine abrogates the adverse effects of antiretroviral pyrimidine analogues on adipose cell functions. Antivir. Ther. 11:25-34.
37. Côté HC. 2005. Possible ways nucleoside analogues can affect mitochondrial DNA content and gene expression during HIV therapy. Antivir. Ther. 10(Suppl 2):M3-M11.
38. Mallon PW, Unemori P, Sedwell R, Morey A, Rafferty M, Williams K, Chisholm D, Samaras K, Emery S, Kelleher A, Cooper DA, Carr A. 2005. In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA. J. Infect. Dis. 191:1686-1696.
39. Pace CS, Martin AM, Hammond EL, Mamotte CD, Nolan DA, Mallal SA. 2003. Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients. Antivir. Ther. 8:323-331.
40. Wallace DC. 1999. Mitochondrial diseases in man and mouse. Science 283:1482-1488.
41. Payne BA, Wilson IJ, Hateley CA, Horvath R, Santibanez-Koref M, Samuels DC, Price DA, Chinnery PF. 2011. Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of mtDNA mutations. Nat. Genet. 43:806-810.
42. Caron-Debarle M, Lagathu C, Boccara F, Vigouroux C, Capeau J. 2010. HIV-associated lipodystrophy: from fat injury to premature aging. Trends Mol. Med. 16:218-229.